Τόμος 9 (1995) – Τεύχος 2 & 3 – Άρθρο 6 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 9 (1995) – Issue 2 & 3 – Article 6 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title A new generation of antihypertensives: non-peptide angiotensin II receptor antagonists
Authors J. Smith1, A. Wahhab2, J. Hondrelis3, R. Ganter2, D. Moore2,G. Moore2 and J. Matsoukas³

1. Department of Chemistry, University of Exeter, Exeter, Devon, England

2. Department of Pharmacology and Therapeutics, University of Calgary, Calgary, Alberta, Canada

3. Department of Chemistry, University of Patras, Patras, Greece

Citation Smith, J., Wahhab, A., Hondrelis, J., Ganter, R., Moore, D., et al.: A new generation of antihypertensives: non-peptide angiotensin II receptor antagonists, Epitheorese Klin. Farmakol. Farmakokinet. 9(2-3): 75-77 (1995)
Publication Date 1995
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)

pharmakonpress[at]pharmakonpress[.]gr

Keywords Angiotensin II, peptidomimetic antagonists, antihypertensives.
Other Terms review article
Summary Blockade of the renin-angiotensin system is of primary importance in the treatment of hypertension and congestive heart failure. A breakthrough came with the development of angiontensin converting enzyme (ACE) inhibitors that suppress angiotensin biosynthesis. A more selective approach has now been realised through the discovery of imidazole-based non-peptide angiotensin II (ANGII) receptor antagonists. Lead compounds in this series of novel therapeutics agents all maintain the same substitution pattern around the imidazole nucleus. To investigate the effect of changing the orientation of the imidazole ring on biological activity, a series of analogues was prepared and evaluated as ANGII receptor antagonists in vitro, and as antihypertensive agents in vivo. The findings of this study will be discussed in relation to developments within this field.
References
Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 1995 – ANNUAL SUBSCRIPTION 1995
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

Bookmark the permalink.

Comments are closed.